Archive: 25/01/2012

Spin-out targets better cancer treatment

A new Oxford University spin-out firm, Oxford Cancer Biomarkers Limited, is to develop technology to ensure that only patients who are likely to benefit from anti-cancer drugs will receive them and that the best treatment ...

Potential for earlier diagnosis of ovarian cancer

(Medical Xpress) -- Australian scientists have identified biochemical changes that commonly occur in the DNA of women with ovarian cancer, which may help diagnose the cancer at an earlier stage in the future.

page 4 from 6